Cumulative false positive recall rate and association with participant related factors in a population based breast cancer screening programme

Journal of Epidemiology and Community Health
Xavier CastellsFrancesc Macià

Abstract

To investigate the cumulative false positive recall rate throughout the period of participation in a population based breast cancer screening programme and to examine its association with women related factors. Analysis of a database to estimate the cumulative false positive recall rate after 10 biennial mammograms in a cohort of women. Cumulative risk after 10 rounds was calculated by projecting forward the information available on the four rounds. Logistic regression was used to evaluate the association between the cumulative risk of false positive recall and women related factors. Population based breast cancer screening programme in Barcelona City (Spain). 8502 women aged 50-69 years who participated in four consecutive screening rounds. Eligible women had received a mammogram in the first screening round between 1 December 1995 and 31 December 1996. The false positive recall rate in the first screening for women who entered the screening programme at the age of 50-51 years was assessed at 10.6% (95% CI 8.9, 12.3). In the second screening this risk decreased to 3.8% (95% CI 2.7, 4.9) and remained almost constant in subsequent rounds. After 10 mammograms, the cumulative false positive recall rate was estimated at 32.4% (95% ...Continue Reading

References

Apr 15, 1991·Annals of Internal Medicine·C LermanP F Engstrom
Jun 1, 1991·The British Journal of Radiology·A R Bull, M J Campbell
Nov 24, 1993·JAMA : the Journal of the American Medical Association·K KerlikowskeV Ernster
Apr 17, 1998·The New England Journal of Medicine·J G ElmoreS W Fletcher
Jun 27, 2000·Statistics in Medicine·A E Gelfand, F Wang
Oct 19, 2000·Journal of the National Cancer Institute·C L ChristiansenS W Fletcher
Mar 7, 2002·Journal of the National Cancer Institute·Laura EssermanAlastair Gale
Feb 20, 2003·Journal of the National Cancer Institute·Craig A BeamEdward A Sickles
May 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·E LyngeJ Patnick
Jul 5, 2003·BMC Medical Research Methodology·Stuart G BakerBarnett S Kramer
Jul 12, 2003·BMJ : British Medical Journal·Hazel ThorntonMichael Baum
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C LampicP-O Sjödén
Dec 30, 2004·Journal of Medical Screening·B C YankaskasUNKNOWN International Breast Cancer Screening Network
Jan 11, 2005·Lancet·Suzanne W Fletcher, Joann G Elmore
Mar 10, 2005·BMJ : British Medical Journal·Alexandra BarrattNehmat Houssami
Apr 9, 2005·Journal of Medical Screening·Rebecca Smith-BindmanKarla Kerlikowske

❮ Previous
Next ❯

Citations

Jun 7, 2011·European Radiology·Raquel Zubizarreta AlberdiUNKNOWN CFPR (Cumulative False Positive Risk) group(1)
Sep 9, 2011·European Radiology·Nieves AscunceUNKNOWN Cumulative False Positive Risk (CFPR) Group
Jul 29, 2008·Breast Cancer Research and Treatment·Suzanne M O'NeillRobert R Edelman
Apr 6, 2012·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Rebecca EspasaXavier Castells
Mar 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R RománX Castells
May 12, 2011·European Journal of Public Health·Dolores Alamo-JunqueraUNKNOWN Cumulative False-Positive Risk Group
Apr 12, 2012·Journal of the National Cancer Institute·My von Euler-ChelpinIlse Vejborg
Apr 2, 2010·Statistical Methods in Medical Research·Rebecca A HubbardRobert A Smith
Apr 29, 2008·BMC Health Services Research·Eduard MolinsXavier Castells
Mar 20, 2013·Annals of Family Medicine·John Brodersen, Volkert Dirk Siersma
Sep 28, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S H Njor, M von Euler-Chelpin
Jun 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J D M OttenA L M Verbeek
May 28, 2011·Breast Cancer Research and Treatment·R RománX Castells
Feb 16, 2016·Radiology·Xavier CastellsUNKNOWN BELE Study Group
Sep 1, 2012·Radiología·M Mellado Rodríguez, A M Osa Labrador
Jul 1, 2011·Gaceta sanitaria·Ana Molina-BarcelóJosefa Miranda García
Mar 20, 2012·Gaceta sanitaria·María SalaUNKNOWN en nombre de los grupos de investigación RAFP e INCA
May 18, 2011·Preventive Medicine·Dolores SalasUNKNOWN CFPR (Cumulative False Positive Risk) group
Mar 17, 2009·Gaceta sanitaria·Xavier CastellsMontserrat Casamitjana
May 28, 2015·Cancer Epidemiology·Katja Kemp JacobsenSisse Helle Njor
Nov 26, 2015·Revista de calidad asistencial : organo de la Sociedad Española de Calidad Asistencial·M D Moreno-Ramos, E Ruíz-García
Jul 19, 2014·Cancer Epidemiology·My von Euler-ChelpinIlse Vejborg
May 22, 2016·Japanese Journal of Clinical Oncology·Chisato HamashimaUNKNOWN Japanese Research Group for the Development of Breast Cancer Screening Guidelines
Oct 18, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Mathijs C GoossensEliane Kellen
Jun 2, 2012·Journal of Medical Screening·Montse GarciaVíctor Moreno
Jun 6, 2013·The Cochrane Database of Systematic Reviews·Peter C Gøtzsche, Karsten Juhl Jørgensen
Jun 20, 2012·The Medical Journal of Australia·Marcus J H SimElizabeth J Wylie
Jan 2, 2016·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca A HubbardDiana L Miglioretti
Sep 7, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gemma Ibáñez-SanzUNKNOWN Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study Working Group
Jan 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R RománX Castells
Sep 26, 2008·Gaceta sanitaria·Blanca Lumbreras, Ildefonso Hernández Aguado

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Rubén RománXavier Castells
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
C LampicP O Sjödén
© 2021 Meta ULC. All rights reserved